ALTERNATIVE VIEWS

Walter A. Brown's Opinion piece, "Alternative Medicine: It's Time to Get Smart," (The Scientist, 12[24]:13, Dec. 7, 1998) is timely and balanced. It is wishful thinking to argue that no placebo-controlled clinical studies are needed because herbs and the like have been used for hundreds of years. Those of us who have worked in pharmaceutical R&D for decades have seen too many compounds that were sworn efficacious by both physicians and patients, but could not be shown superior to a placebo.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Walter A. Brown's Opinion piece, "Alternative Medicine: It's Time to Get Smart," (The Scientist, 12[24]:13, Dec. 7, 1998) is timely and balanced. It is wishful thinking to argue that no placebo-controlled clinical studies are needed because herbs and the like have been used for hundreds of years. Those of us who have worked in pharmaceutical R&D for decades have seen too many compounds that were sworn efficacious by both physicians and patients, but could not be shown superior to a placebo. All claims made by the purveyors of "alternative" medicines should have to be proven in controlled studies.

A second area that should be seriously addressed is safety. If nobody carefully follows up on the use of a medication in the population, side effects will not likely be detected unless they are serious and have high incidence. Plant products, if they are active, owe their efficacy to plant chemicals that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Charles Smith

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo